Compare Citius Pharmaceuticals Inc (CTXR) vs Cytokinetics Inc (CYTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Cytokinetics Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Cytokinetics Inc trades at $76.45 (market cap $10.63B). The key difference: Cytokinetics Inc is far larger — about 531.2× Citius Pharmaceuticals Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | CYTK | |
|---|---|---|
Market Cap | $20.01M | $10.63B |
Sector | Health | Technology |
52-Week High | $1.82 | $87.26 |
52-Week Low | $0.48 | $34.31 |
Enterprise Value | $16.23M | $10.74B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →
